Citation: Lc. Hsu et Sk. Schwarcz, USE OF PROTEASE INHIBITORS AND SURVIVAL AMONG PERSONS WITH AIDS, American journal of epidemiology, 147(11), 1998, pp. 311-311
Authors:
SCHWARCZ SK
SPITTERS C
GINSBERG MM
ANDERSON L
KELLOGG T
KATZ MH
Citation: Sk. Schwarcz et al., PREDICTORS OF HUMAN-IMMUNODEFICIENCY-VIRUS COUNSELING AND TESTING AMONG SEXUALLY-TRANSMITTED DISEASE CLINIC PATIENTS, Sexually transmitted diseases, 24(6), 1997, pp. 347-352
Citation: Sk. Schwarcz et al., RETROSPECTIVE DIAGNOSIS OF A FATAL CASE OF THE HANTAVIRUS PULMONARY SYNDROME, 1980, Western journal of medicine, 164(4), 1996, pp. 348-350
Authors:
SCHWARCZ SK
KELLOGG TA
KOHN RP
KATZ MH
LEMP GF
BOLAN GA
Citation: Sk. Schwarcz et al., TEMPORAL TRENDS IN HUMAN-IMMUNODEFICIENCY-VIRUS SEROPREVALENCE AND SEXUAL-BEHAVIOR AT THE SAN-FRANCISCO MUNICIPAL SEXUALLY-TRANSMITTED DISEASE CLINIC, 1989-1992, American journal of epidemiology, 142(3), 1995, pp. 314-322
Authors:
SCHWARCZ SK
BOLAN GA
KELLOGG TA
KOHN R
LEMP GF
Citation: Sk. Schwarcz et al., COMPARISON OF VOLUNTARY AND BLINDED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) SEROPREVALENCE SURVEYS IN A HIGH PREVALENCE SEXUALLY-TRANSMITTED DISEASE CLINIC POPULATION, American journal of epidemiology, 137(6), 1993, pp. 600-608